| Copper | Approved Investigational | EEPD1 | 80820 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of EEPD1 mRNA | 7p14.2 | |
| Copper | Approved Investigational | EFCAB2 | 84288 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of EFCAB2 mRNA | 1q44 | |
| Copper | Approved Investigational | EFEMP1 | 2202 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of EFEMP1 mRNA | 2p16.1 | |
| Copper | Approved Investigational | EFEMP1 | 2202 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of EFEMP1 mRNA | 2p16.1 | |
| Copper | Approved Investigational | EFHD2 | 79180 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of EFHD2 mRNA | 1p36.21 | |
| Copper | Approved Investigational | EFNB2 | 1948 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of EFNB2 mRNA | 13q33.3 | |
| Copper | Approved Investigational | EGF | 1950 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of EGF mRNA | 4q25 | |
| Copper | Approved Investigational | EGFR | 1956 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of EGFR mRNA | 7p11.2 | |
| Copper | Approved Investigational | EGLN3 | 112399 |
upregulated | [Organoselenium Compounds binds to Copper] which results in increased expression of EGLN3 mRNA | 14q13.1 | |
| Copper | Approved Investigational | EGR1 | 1958 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of EGR1 mRNA | 5q31.2 | |
| Copper | Approved Investigational | EGR1 | 1958 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of EGR1 mRNA | 5q31.2 | |
| Copper | Approved Investigational | EHF | 26298 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of EHF mRNA | 11p13 | |
| Copper | Approved Investigational | EI24 | 9538 |
downregulated | Copper results in decreased expression of EI24 mRNA | 11q24.2 | |
| Copper | Approved Investigational | EI24 | 9538 |
upregulated | [Copper results in increased activity of TP53 protein] which results in increased expression of EI24 mRNA | 11q24.2 | |
| Copper | Approved Investigational | EIF1 | 10209 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of EIF1 mRNA | 17q21.2 | |
| Copper | Approved Investigational | EIF1AX | 1964 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of EIF1AX mRNA | Xp22.12 | |
| Copper | Approved Investigational | EIF3A | 8661 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of EIF3A mRNA | 10q26.11 | |
| Copper | Approved Investigational | EIF4A3 | 9775 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of EIF4A3 mRNA | 17q25.3 | |
| Copper | Approved Investigational | EIF5 | 1983 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of EIF5 mRNA | 14q32.32 | |
| Copper | Approved Investigational | EIF5A2 | 56648 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of EIF5A2 mRNA | 3q26.2 | |
| Copper | Approved Investigational | ELAVL2 | 1993 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of ELAVL2 mRNA | 9p21.3 | |
| Copper | Approved Investigational | ELL2 | 22936 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of ELL2 mRNA | 5q15 | |
| Copper | Approved Investigational | ELOF1 | 84337 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of ELOF1 mRNA | 19p13.2 | |
| Copper | Approved Investigational | ELP6 | 54859 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of ELP6 mRNA | 3p21.31 | |
| Copper | Approved Investigational | EMB | 133418 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of EMB mRNA | 5q11.1 | |